Phytoestrogens as Anticancer Therapeutics: A Retrospective and Future Perspectives

References

• Craig, W.J. (1997). Phytochemicals: guardians of our health. Journal of the American Dietetic Association. 97: S199–S204. doi: 10.1016/S0002-8223(97)00765-7
   PubMed Web of Science ®Google Scholar
• Murkies, A.L., Wilcox, G., Davis, S.R. (1998). Phytoestrogens. Journal of Clinical Endocrinology & Metabolism. 83: 297–303.
   PubMed Web of Science ®Google Scholar
• Dixon, R.A. (2004). Phytoestrogens. Annual Review of Plant Biology. 55: 225–261. doi: 10.1146/annurev.arplant.55.031903.141729
   PubMed Web of Science ®Google Scholar
• Cornwell, T., Cohick, W., Raskin, I. (2004). Dietary phytoestrogens and health. Phytochemistry. 65: 995–1016. doi: 10.1016/j.phytochem.2004.03.005
   PubMed Web of Science ®Google Scholar
• Rishi, R.K. (2002). Phytoestrogens in health and illness. Indian Journal of Pharmacology. 34: 311–320.
   Google Scholar
• National Academy of Sciences. (1982). Diet, nutrition, and cancer. Washington, DC; National Academy Press.
   Google Scholar
• Lissin, L.W., Cooke, J.P. (2000). Phytoestrogens and cardiovascular health. Journal of the American College of Cardiology. 35: 1403–1410. doi: 10.1016/S0735-1097(00)00590-8
   PubMed Web of Science ®Google Scholar
• Cos, P., De Bruyne, T., Apers, S., Berghe, D.V., Pieters, L., Vlietinck, A.J. (2003). Phytoestrogens: recent developments. PlantaMedica. 69: 589–599.
   Web of Science ®Google Scholar
• Aldercreutz, H. (1998). Epidemiology of phytoestrogens. Bailliere’s Clinical Endocrinology and Metabolism. 12: 605–623. doi: 10.1016/S0950-351X(98)80007-4
   PubMedGoogle Scholar
• Knight, D.C., Eden, J.A. (1996). A review of the clinical effects of phytoestrogens. Obstetrics and Gynecology, 87: 897–904.
   PubMed Web of Science ®Google Scholar
• Limer, J.L., Speirs, V. (2004). Phyto-oestrogens and breast cancer chemoprevention. Breast Cancer Research. 6: 119–132. doi: 10.1186/bcr781
   PubMed Web of Science ®Google Scholar
• Adlercreutz, H. (1990). Western diet and western diseases: Some hormonal and biochemical mechanisms and associations. Scandinavian Journal of Clinical and Laboratory Investigation. 50: 3–23. doi: 10.1080/00365519009085798
   Web of Science ®Google Scholar
• Burow, M.E., Boue, S.M., Collins-Burow, B.M., Melnik, L.I., Duong, B.N., Carter-Wientjes, C.H., Li, S., Wiese, T.E., Cleveland, T.E., McLachlan, J.A. (2001). Phytochemical glyceollins, isolated from soy, mediate hormonaleffects through estrogen receptor α and β. Journal of Clinical Endocrinology and Metabolism. 86: 1750–1758.
   PubMed Web of Science ®Google Scholar
• Le Bail, J.C., Champavier, Y., Chulia, A.J, Habrioux, G. (2001). Effects of phytoestrogens on aromatase, 3β and 17β-hydroxysteroid dehydrogenase activities and human breast cancer cells. LifeScience. 66: 1281–1291. doi: 10.1016/S0024-3205(00)00435-5
   Google Scholar
• Rosenberg, Z.R.S., Jenkins, D.J.A., Diamandis, E.P. (2000). Steroid hormone activity of flavonoids and related compounds. Breast Cancer Research and Treatment. .62: 35–49. doi: 10.1023/A:1006422302173
   PubMed Web of Science ®Google Scholar
• Kiyama, R. (2017). Estrogenic terpenes and terpenoids: Pathways, functions and applications. European Journal of Pharmacology. 815: 405–415. doi: 10.1016/j.ejphar.2017.09.049
   PubMed Web of Science ®Google Scholar
• Geuns, J.M. (1978). Steroid hormones and plant growth and development. Phytochemistry. 17: 1–14. doi: 10.1016/S0031-9422(00)89671-5
   Web of Science ®Google Scholar
• Bingham, S.A,. Atkinson, C., Liggins, J., Bluck, L., Coward, A. (1998). Phyto-oestrogens: Where are we now? British journal of nutrition, 79: 393–406. doi: 10.1079/BJN19980068
   PubMed Web of Science ®Google Scholar
• Setchell, K.D.R. (1998). Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. American Journal of Clinical Nutrition. 68: 1333S–1346S. doi: 10.1093/ajcn/68.6.1333S
   PubMed Web of Science ®Google Scholar
• Barnes, S., Kirk, M., Coward, L. (1994). Isoflavones and their conjugates in soy foods: Extraction conditions and analysis by HPLC-mass spectrometry. Journal of Agricultural and Food Chemistry, 42: 2466–2474. doi: 10.1021/jf00047a019
   Web of Science ®Google Scholar
• Anderson, J.J.B., Anthony, M., Messina, M., Garner, S.C. (1999). Effects of phyto-estrogens on tissues. Nutrition research reviews. 12: 75–116. doi: 10.1079/095442299108728875
   PubMed Web of Science ®Google Scholar
• Axelson, M., Sjovall, J., Gustafsson, B., Setchell, K.D.R. (1982). Origin of lignans in mammals and identification of a precursor from plants. Nature. 298: 659–660. doi: 10.1038/298659a0
   PubMed Web of Science ®Google Scholar
• Adlercreutz, H., Höckerstedt, K., Bannwart, C., Bloigu, S., Hämäläinen, E., Fotsis, T., Ollus, A. (1987). Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). Journal of Steroid Biochemistry. 27: 1135–1144. doi: 10.1016/0022-4731(87)90200-7
   PubMedGoogle Scholar
• Hutchins, A.M., Lampe, J.W., Martini, M.C., Campbell, D.R., Slavin, J.L. (1995). Vegetables, fruits and legumes: Effect on urinary isoflavonoid phytoestrogen and lignan excretion. Journal of the American Dietetic Association. 95: 769–774. doi: 10.1016/S0002-8223(95)00214-6
   PubMedGoogle Scholar
• Virk-Baker, M.K., Nagy, T.R., Barnes, S. (2010). Role of phytoestrogens in cancer therapy. Planta Medica. 76: 1132–1142. doi: 10.1055/s-0030-1250074
   PubMed Web of Science ®Google Scholar
• Key, T.J.A., Beral, V. (1992). Sex hormones and cancer. In: Mechanisms of Carcinogenesis in Risk Identification. Eds. H. Vainio, P. N. Magee, D.B. McGregor and A.J. McMichael. IARC Scientific Publications, Lyon. p. 116: 255.
   Google Scholar
• Sharma, B.K., Ray, A. (2000). Breast and prostate cancer. Indian Journal of Clinical Biochemistry. 15: 110. doi: 10.1007/BF02867550
   PubMedGoogle Scholar
• English, M.A., Stewart, P.M., Hewison, M. (2001). Estrogen metabolism and malignancy: analysis of the expression and function of 17 beta-hydroxysteroid dehydrogenases in colonic cancer. Molecular and Cellular Endocrinology. 171: 53. doi: 10.1016/S0303-7207(00)00418-4
   PubMed Web of Science ®Google Scholar
• Ray, A., Gupta, S. (2001). Some facts about gall-bladder cancer. ICPO Newsletter, 3: 6.
   Google Scholar
• Li, S.A., Klicka, J.K. Li, J.J. (1985). Estrogen 2- and 4- hydroxylase activity, catechol estrogen formation, and implications for estrogen carcinogenesis in the hamster kidney. Cancer research. 45: 181.
   PubMed Web of Science ®Google Scholar
• Yager, J.D. (2000). Endogenous estrogens as carcinogens through metabolic activation. Journal of the National Cancer Institute, Monographs. 27: 67. doi: 10.1093/oxfordjournals.jncimonographs.a024245
   PubMedGoogle Scholar
• Lippman, M., Bolan, G., Huff, K. (1976). The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer research. 36: 4595–4601.
   PubMed Web of Science ®Google Scholar
• Nilsson, S., Mäkelä, S., Treuter, E., Tujague, M., Thomsen, J., Andersson, G., Enmark, E., Pettersson, K., Warner, M., Gustafsson, J.Å. (2001). Mechanisms of estrogen action. Physiological reviews. 81: 1535–1565. doi: 10.1152/physrev.2001.81.4.1535
   PubMed Web of Science ®Google Scholar
• Hall, J.M., Couse, J.F., Korach, K.S. (2001). The multifaceted mechanisms of estradiol and estrogen receptor signaling. Journal of Biological Chemistry. 276: 36869–36872. doi: 10.1074/jbc.R100029200
   PubMed Web of Science ®Google Scholar
• Horwitz, K.B., McGuire, W.L. (1978). Nuclear mechanisms of estrogen action: effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing. Journal of Biological Chemistry. 253: 8185–8191.
   PubMed Web of Science ®Google Scholar
• Malumbres, M., Barbacid, M. (2001). Milestones in cell division: to cycle or not to cycle: a critical decision in cancer. Nature Reviews Cancer. 1: 222–231. doi: 10.1038/35106065
   PubMed Web of Science ®Google Scholar
• Fritsch, M. J. (1994). Long-term tamoxifen therapy for the treatment of breast cancer. Cancer Control. 1: 356–366.
   PubMedGoogle Scholar
• Rossouw, J.E., Anderson, G.L., Prentice, R.L., LaCroix, A.Z., Kooperberg, C., Stefanick, M.L., Jackson, R.D., Beresford, S.A., Howard, B.V., Johnson, K.C., Kotchen, J.M., Ockene, J. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trial. Journal of the American Medical Association. 288: 321–333. doi: 10.1001/jama.288.3.321
   PubMed Web of Science ®Google Scholar
• Cummings, S.R., Eckert, S., Krueger, K.A., Grady, D., Powles, T.J., Cauley, J.A., Norton, L., Nickelsen, T., Bjarnason, N.H., Morrow, M., Lippman, M.E., Black, D., Glusman, J.E., Costa, A., Jordan, V.C. (1999). The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the more randomized trial. Multiple outcomes of raloxifene evaluation. Journal of the American Medical Association. 281: 2189–2197. doi: 10.1001/jama.281.23.2189
   PubMed Web of Science ®Google Scholar
• Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., Fukami, Y. (1987). Genistein, a specific inhibitor of tyrosine-specific protein kinases. Journal of Biological Chemistry. 262: 5592–5595.
   PubMed Web of Science ®Google Scholar
• Davis, J.N., Kucuk, O., Sarkar, F.H. (1999). Genistein inhibits NF-kappa B activation in prostate cancer cells. Nutrition and Cancer. 35: 167–174. doi: 10.1207/S15327914NC352_11
   PubMed Web of Science ®Google Scholar
• Krazeisen, A., Breitling, R., Moller, G., Adamski, J. (2001). Phytoestrogens inhibit human 17beta-hydroxysteroid dehydrogenase type 5. Molecular and Cellular Endocrinology. 171: 151–162. doi: 10.1016/S0303-7207(00)00422-6
   PubMed Web of Science ®Google Scholar
• Rice, S., Mason, H.D., Whitehead, S.A. (2006). Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulosa-luteal cells. The Journal of Steroid Biochemistry and Molecular Biology. 101: 216–225. doi: 10.1016/j.jsbmb.2006.06.021
   PubMed Web of Science ®Google Scholar
• Dang, Z.C., Audinot. V., Papapoulos. S.E., Boutin. J.A., Lowik. C.W. (2003). Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein. Journal of Biological Chemistry. 278: 962–967. doi: 10.1074/jbc.M209483200
   PubMed Web of Science ®Google Scholar
• Chacko, B.K., Chandler, R.T., Mundhekar, A., Khoo, N., Pruitt, H.M., Kucik, D.F., Parks, D.A., Kevil, C.G., Barnes, S., Patel, R.P. (2005). Revealing anti-inflammatory mechanisms of soy isoflavones by flow: modulation of leukocyte-endothelial cell interactions. American Journal of Physiology-Heart and Circulatory Physiology. 289: H908–H915. doi: 10.1152/ajpheart.00781.2004
   PubMed Web of Science ®Google Scholar
• Wu, A.H., Ziegler, R.G., Horn-Ross, P.L., Nomura, A.M., West, D.W., Kolonel, L.N., Rosenthal, J.F., Hoover, R.N., Pike, M.C. (1996). Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiology and Prevention Biomarkers. 5: 901–906.
   PubMed Web of Science ®Google Scholar
• Kurahashi, N., Iwasaki, M., Sasazuki, S., Otani, T., Inoue, M., Tsugane, S. (2007). Soy product and isoflavone consumption in relation to prostate cancer in Japanese men. Cancer Epidemiology, Biomarkers and Prevention. 16: 538–545. doi: 10.1158/1055-9965.EPI-06-0517
   PubMed Web of Science ®Google Scholar
• Busby, M.G., Jeffcoat, A.R., Bloedon, L.T., Koch, M.A., Black, T., Dix, K.J., Heizer, W.D., Thomas, B.F., Hill, J.M., Crowell, J.A., Zeisel, S.H. (2002). Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men. American Journal of Clinical Nutrition. 75: 126–136. doi: 10.1093/ajcn/75.1.126
   PubMed Web of Science ®Google Scholar
• Bloedon, L.T., Jeffcoat, A.R., Lopaczynski, W., Schell, M.J., Black, T.M., Dix, K.J., Thomas, B.F., Albright, C., Busby, M.G., Crowell, J.A., Zeisel, S.H. (2002). Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women. American Journal of Clinical Nutrition. 76: 1126–1137. doi: 10.1093/ajcn/76.5.1126
   PubMed Web of Science ®Google Scholar
• Morito, K., Hirose, T., Kinjo, J., Hirakawa, T., Okawa, M., Nohara, T., Ogawa, S., Inoue, S., Muramatsu, M., Masamune, Y. (2001). Interaction of phytoestrogens with estrogen receptors alpha and beta. Biological and Pharmaceutical Bulletin. 24: 351–356. doi: 10.1248/bpb.24.351
   PubMed Web of Science ®Google Scholar
• Morito, K., Aomori, T., Hirose, T., Kinjo, J., Hasegawa, J., Ogawa, S., Inoue, S., Muramatsu, M. Masamune, Y. (2002). Interaction of phytoestrogens with estrogen receptors α and α (II). Biological and Pharmaceutical Bulletin. 25: 48–52. doi: 10.1248/bpb.25.48
   PubMed Web of Science ®Google Scholar
• Ranich, T., Bhathena, S.J., Velasquez, M.T. (2001). Protective effects of dietary phytoestrogens in chronic renal disease. Journal of Renal Nutrition. 11: 183–193. doi: 10.1016/S1051-2276(01)70036-2
   PubMed Web of Science ®Google Scholar
• Arena, B., Maffulli, N. (2002). Endocrinologic changes in exercising women. Sports medicine and arthroscopy review. 10(1): 10–14. doi: 10.1097/00132585-200210010-00003
   Web of Science ®Google Scholar
• Setchell, K.D.R. (2001). Soy isoflavones-benefits and risks from nature’s selective estrogen receptor modulators (SERMs). Journal of the American College of Nutritio. 20: 354S–362S; discussion 381S-383S. doi: 10.1080/07315724.2001.10719168
   PubMed Web of Science ®Google Scholar
• Brzezinski, A., Debi, A. (1999). Phytoestrogens: the “natural” selective estrogen receptor modulators. European Journal of Obstetrics & Gynecology and Reproductive Biology. 85: 57–61. doi: 10.1016/S0301-2115(98)00281-4
   PubMed Web of Science ®Google Scholar
• Markovits, J., Linassier, C., Fossé, P., Couprie, J., Pierre, J., Jacquemin-Sablon, A., Saucier, J.M., Le Pecq, J.B., Larsen, A.K. (1989). Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Research. 49: 5111–5117.
   PubMed Web of Science ®Google Scholar
• Peterson, T.G., Barnes, S. (1996). Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differentiation. 7: 1345–1351.
   PubMedGoogle Scholar
• Kim, H., Peterson, T.G., Barnes, S. (1998). Mechanisms of action of the soy isoflavonegenistein: Emerging role for its effects via transforming growth factor-b signaling pathways. American Journal of Clinical Nutrition. 68: 1418S–1425S. doi: 10.1093/ajcn/68.6.1418S
   PubMed Web of Science ®Google Scholar
• Wei, H., Bowen, R., Cai, Q., Barnes, S., Wang, Y. (1995). Antioxidant and antiproliferative effects of the soybean isoflavonegenistein. Proceedings of the Society for Experimental Biology and Medicine. 208: 124–130. doi: 10.3181/00379727-208-43844
   PubMed Web of Science ®Google Scholar
• Fotsis, T., Peper, M., Adlercreutz, H., Fleischmann, G., Hase, T., Montesano, R., Schweigerer, L. (1993). A dietary derived inhibitor of angiogenesis. Proceedings of the National Academy of Sciences of the United States of America. 90: 2690–2694. doi: 10.1073/pnas.90.7.2690
   PubMed Web of Science ®Google Scholar
• Maggiolini, M., Bonofiglio, D., Marsico, S., Panno, M.L., Cenni, B., Picard, D., Andò, S. (2001). Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Molecular Pharmacology. 60: 595–602.
   PubMed Web of Science ®Google Scholar
• Adlercreutz, H. (1990). Western diet and western diseases: Some hormonal and biochemical mechanisms and associations. Scandinavian Journal of Clinical and Laboratory Investigation. 50: 3–23. doi: 10.1080/00365519009085798
   Web of Science ®Google Scholar
• Aldercreutz, H., Fotsis, T., Lampe, J., Wahala, K., Makela, T., Brunow, G., Hase, T. (1993). Quantitative determination of lignans and isoflavones in plasma of omnivorous and vegetarian women by isotope-dilution gas chromatography-mass spectrometry. Scandinavian Journal of Clinical and Laboratory Investigation. 53: 5–18. doi: 10.3109/00365519309090693
   Web of Science ®Google Scholar
• Lamartiniere, C.A., Zhang, J.X., Cotroneo, M.S. (1998). Genistein studies in rats: potential for breast cancer prevention and reproductive and developmental toxicity. American Journal of Clinical Nutrition. 1400S–1405S. doi: 10.1093/ajcn/68.6.1400S
   PubMed Web of Science ®Google Scholar
• Lamartiniere, C.A. (2000). Protection against breast cancer with genistein: a component of soy. American Journal of Clinical Nutrition. 1705S–1707S. doi: 10.1093/ajcn/71.6.1705S
   PubMed Web of Science ®Google Scholar
• Banerjee, S., Bueso-Ramos, C., Aggarwal, B.B. (2002). Suppression of 7,12-dimethyl(a) anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-B, cyclooxygenase 2 and matrix metalloprotease 9. Cancer Research. 62: 4945–4954.
   PubMed Web of Science ®Google Scholar
• Jin, Z., MacDonald, R.S. (2002). Soy isoflavones increase latency of spontaneous mammary tumours in mice. Journal of Nutrition. 132: 3186–3190. doi: 10.1093/jn/131.10.3186
   PubMed Web of Science ®Google Scholar
• Gallo, D., Giacomelli, S., Cantelmo, F., Zannoni, G.F., Ferrandina, G., Fruscella, E., Riva, A., Morazzoni, P., Bombardelli, E., Mancuso, S., Scambia, G. (2001). Chemoprevention of DMBA-induced mammary cancer in rats by dietary soy. Breast Cancer Research and Treatment. 69: 153–164. doi: 10.1023/A:1012414119944
   PubMed Web of Science ®Google Scholar
• Yan, L., Li, D., Yee, J.A. (2002). Dietary supplementation with isolated soy protein reduces metastasis of mammary carcinoma cells in mice. Clinical & Experimental Metastasis. 19: 535–540. doi: 10.1023/A:1020377311532
   PubMed Web of Science ®Google Scholar
• Darby, I.A., Hewitson, T. D. (2007). Fibroblast differentiation inwound healing and fibrosis. International Review of Cytology. 257: 143–179. doi: 10.1016/S0074-7696(07)57004-X
   PubMed Web of Science ®Google Scholar
• Coussens, L.M., Werb, Z. (2002). Inflammation and cancer. Nature. 420: 860–867. doi: 10.1038/nature01322
   PubMed Web of Science ®Google Scholar
• Ditsworth, D, Zong, W.X. (2004). NF-kappaB: key mediator of inflammation-associated cancer. Cancer Biology & Therapy, 3: 1214–1216. doi: 10.4161/cbt.3.12.1391
   PubMed Web of Science ®Google Scholar
• Sandler, R.S., Halabi, S., Baron, J.A., Budinger, S., Paskett, E., Keresztes, R., Petrelli, N., Pipas, J.M., Karp, D.D., Loprinzi, C.L., Steinbach, G., Schilsky, R. (2003). A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. New England Journal of Medicine. 348: 883–890. doi: 10.1056/NEJMoa021633
   PubMed Web of Science ®Google Scholar
• Chan, A.T. (2003). Aspirin, non-steroidal anti-inflammatory drugs and colorectal neoplasia: future challenges in chemoprevention. Cancer Causes Control. 14: 413–418. doi: 10.1023/A:1024986220526
   PubMed Web of Science ®Google Scholar
• Chan, A.T., Giovannucci, E.L., Meyerhardt, J.A., Schernhammer, E.S., Curhan, G.C., Fuchs, C.S. (2005). Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. Journal of the American Medical Association. 294: 914–923. doi: 10.1001/jama.294.8.914
   PubMed Web of Science ®Google Scholar
• Flossmann, E., Rothwell, P.M. (2007). Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet. 369: 1603–1613. doi: 10.1016/S0140-6736(07)60747-8
   PubMed Web of Science ®Google Scholar
• Krenn, L., Paper, D.H. (2009). Inhibition of angiogenesis and inflammation by an extract of red clover (Trifolium pratense L.). Phytomedicine. 16: 1083–1088. doi: 10.1016/j.phymed.2009.05.017
   PubMed Web of Science ®Google Scholar
• Hwang, J.T., Lee. Y.K., Shin, J.I., Park, O.J. (2009). Anti-inflammatory and anti carcinogenic effect of genistein alone or in combination with capsaicin in TPA treated rat mammary glands or mammary cancer cell line. Annals of the New York Academy of Sciences. 1171: 415–420. doi: 10.1111/j.1749-6632.2009.04696.x
   PubMed Web of Science ®Google Scholar
• Grody, W.W. (1994). Breast and prostate cancer. American Journal of Clinical Pathology. 1: S1.
   Google Scholar
• Parkin, D.M., Pisani, P., Ferlay, J. (1995). Estimates of worldwide incidence of major cancers in 1995. International Journal of Cancer. 54: 594.
   Web of Science ®Google Scholar
• Parkin, D.M., Bray, F.I., Devesa, S.S. (2001). Cancer burden in the year 2000: The global picture. European Journal of Cancer. 37: 4. doi: 10.1016/S0959-8049(01)00267-2
   PubMed Web of Science ®Google Scholar
• Adlercreutz, H. (2002). Phyto-oestrogens and cancer. Lancet Oncology. 3: 364. doi: 10.1016/S1470-2045(02)00777-5
   PubMed Web of Science ®Google Scholar
• Lee, H.P., Lee, J., Gourley, L., Duffy, S.W., Day, N.E., Estève, J. (1991). Dietary effects on breast-cancer risk in Singapore. The Lancet. 337: 1197–1200. doi: 10.1016/0140-6736(91)92867-2
   PubMed Web of Science ®Google Scholar
• Axelson, M., Sjovall, J., Gustafsson, B.E. (1984). Soya - a dietary source of the nonsteroidal estrogen equol in man and animals. Journal of Endocrinology. 102: 49–56. doi: 10.1677/joe.0.1020049
   PubMed Web of Science ®Google Scholar
• Price, K.R., Fenwick, G.R. (1985). Naturally occurring oestrogens in foods-a review. Food Additives and Contaminants. 2: 73–106. doi: 10.1080/02652038509373531
   PubMed Web of Science ®Google Scholar
• Messina, M., Messina, V. (1991). Increasing use of soy foods and their potential role in cancer prevention. Journal of the American Dietetic Association. 91: 836–840.
   PubMed Web of Science ®Google Scholar
• Wang, H.J., Murphy, P.A. (1996). Mass balance study of isoflavones during soybean processing. Journal of Agricultural and Food Chemistry. 44: 2377–2383. doi: 10.1021/jf950535p
   Web of Science ®Google Scholar
• Knight, D.C., Eden, J. (1995). Phytoestrogens- a short review. Maturitas. 22: 167–175. doi: 10.1016/0378-5122(95)00937-G
   PubMed Web of Science ®Google Scholar
• Setchell, K.D.R., Adlercreutz, H. (1988). Mammalian lignans and phytoestrogens. Recent studies on their formation, metabolism, and biological role in health and disease. In: Rowland I, ed. Role of the gut flora in toxicity and cancer. London: Academic Press. 315–345.
   Google Scholar
• Thompson, L.U., Robb, P., Serraino, M. (1991). Mammalian lignan production from various foods. Nutrittion and Cancer. 16: 43–52. doi: 10.1080/01635589109514139
   PubMed Web of Science ®Google Scholar
• Tham, D. M., Gardner, C.D., Haskell, W.L. (1998). Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological and mechanistic evidence. Journal of Clinical Endocrinology and Metabolism. 83: 2223–2235.
   PubMed Web of Science ®Google Scholar
• Cassidy, A., Hanley, B., Lamuela-Raventos, R.M. (2000). Isoflavones, lignans and stilbenes-origins, metabolism and potential importance to human health.Journal of the Science of Food and Agriculture. 80: 1044–1062.
   Google Scholar
• Fioravanti, L., Cappelletti, V., Miodini, P., Ronchi, E., Brivio, M., Di Fronzo, G. (1998). Genistein in the control of breast cancer cellgrowth: insights into the mechanism of action in vitro. Cancer Letter. 130: 143–152. doi: 10.1016/S0304-3835(98)00130-X
   PubMed Web of Science ®Google Scholar
• Constantinou, A.I., Krygier, A.E., Mehta, R.R. (1998). Genistein induces maturation of cultured human breast cancer cells and prevents tumour growth in nude mice. American Journal of Clinical Nutrition. Suppl: 1426S–1430S. doi: 10.1093/ajcn/68.6.1426S
   PubMed Web of Science ®Google Scholar
• Dampier, K., Hudson, E.A., Howells LM, Manson MM, Walker RA, Gescher A. (2001). Differences between human breast cell lines insusceptibility towards growth inhibition by genistein. British Journal of Cancer. 85: 618–624. doi: 10.1054/bjoc.2001.1980
   PubMed Web of Science ®Google Scholar
• Upadhyay, S., Neburi, M., Chinni, S.R., Alhasan, S., Miller, F., Sarkar, F.H. (2001). Differential sensitivity of normal and malignant breast epithelialcells to genistein is partly mediated by p21 WAF1. Clinical Cancer Research. 7: 1782–1789.
   PubMed Web of Science ®Google Scholar
• Knabbe, C., Lippman, M.E., Wakefield, LM., Flanders, K.C., Kasid, A., Derynck, R., Dickson, R.B. (1987). Evidence that transforming growthfactor- is a hormonally regulated negative growth factor in human breast cancer cells. Cell. 48: 417–428. doi: 10.1016/0092-8674(87)90193-0
   PubMed Web of Science ®Google Scholar
• Leung, L.K., Wang, T.T. (2000). Bcl-2 is not reduced in the death of MCF-7 cells at low genistein concentration. Journal ofNutrition. 130: 2922–2926.
   PubMed Web of Science ®Google Scholar
• Sasamura, H., Takahashi, A., Miyao, N., Yanase, M., Masumori, N., Kitamura, H., Itoh, N., Tsukamoto, T. (2002). Inhibitory effect on expression of angiogenic factors by antiangiogenic agents in renal cell carcinoma. British Journal of Cancer. 86: 768–773. doi: 10.1038/sj.bjc.6600152
   PubMed Web of Science ®Google Scholar
• Yashar, C.M., Spanos, W.J., Taylor, D.D., Gercel-Taylor, C. (2005). Potentiation of the radiation effect with genistein in cervical cancer cells. Gynecologic Oncology. 99: 199–205. doi: 10.1016/j.ygyno.2005.07.002
   PubMed Web of Science ®Google Scholar
• Singh, A.V., Franke, A.A., Blackburn, G.L., Zhou, J.R. (2006). Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis. Cancer Research. 66: 1851–1858. doi: 10.1158/0008-5472.CAN-05-1332
   PubMed Web of Science ®Google Scholar
• Raffoul, J.J., Wang, Y., Kucuk, O., Forman, J.D., Sarkar, F.H., Hillman, G.G. (2006). Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC Cancer. 6: 107. doi: 10.1186/1471-2407-6-107
   PubMed Web of Science ®Google Scholar
• Zhang, C., Lv, B., Yi, C., Cui, X., Sui, S., Li, X., Qi, M., Hao, C., Han, B., Liu, Z. (2019). Genistein inhibits human papillary thyroid cancer cell detachment, invasion and metastasis. Journal of Cancer. 10: 737. doi: 10.7150/jca.28111
   PubMed Web of Science ®Google Scholar
• Hsiao, Y.C., Peng, S.F., Lai, K.C., Liao, C.L., Huang, Y.P., Lin, C.C., Lin, M.L., Liu, K.C., Tsai, C.C., Ma, Y.S., Chung, J.G. (2019). Genistein induces apoptosis in vitro and has antitumor activity against human leukemia HL60 cancer cell xenograft growth in vivo. Environmental Toxicology. 34(4): 443–456. doi: 10.1002/tox.22698
   PubMed Web of Science ®Google Scholar
• Vergote, D., Cren-Olivé, C., Chopin, V., Toillon, R.A., Rolando, C., Hondermarck, H., Le Bourhis, X. (2002). (“)-Epigallocatechin (EGC) of green tea induces apoptosis of human breast cancer cells but not of their normal counterparts. Breast Cancer Research and Treatment. 76: 195–201. doi: 10.1023/A:1020833410523
   PubMed Web of Science ®Google Scholar
• Ren, H., Ma, J., Si, L., Ren, B., Chen, X., Wang, D., Hao, W., Tang, X., Li, D., Zheng, Q. (2018). Low Dose of Acacetin Promotes Breast Cancer MCF-7 Cells Proliferation Through the Activation of ERK/PI3K/AKT and Cyclin Signaling Pathway. Recent Patents on Anti-cancer Drug Discovery. 13: 368–377. doi: 10.2174/1574892813666180420154012
   PubMed Web of Science ®Google Scholar
• Sun, H., Yin, M., Qian, W., Yin, H. (2018). Calycosin, a Phytoestrogen Isoflavone, Induces Apoptosis of Estrogen Receptor-Positive MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway. Medical science monitor: International Medical Journal of Experimental and Clinical Research. 24: 6178. doi: 10.12659/MSM.910201
   PubMed Web of Science ®Google Scholar
• Wang, Y., Li, J.J., Chen, Y.M. (2018). Biochanin A extirpates the epithelial mesenchymal transition in a human lung cancer. Experimental and Therapeutic Medicine. 15: 2830–2836.
   PubMed Web of Science ®Google Scholar
• Levenson, A.S., Gehm, B.D., Pearce, S.T., Horiguchi, J., Simons, L.A., Ward, J.E., Jameson, J.L., Jordan, V.C. (2003). Resveratrol acts as an estrogenreceptor (ER) agonist in breast cancer cells stably transfected with ER-α. International Journal of Cancer. 104: 587–596. doi: 10.1002/ijc.10992
   PubMed Web of Science ®Google Scholar
• Pozo-Guisado, E., Alvarez-Barrientos, A., Mulero-Navarro, S., Santiago-Josefat, B., Fernandez-Salguero, P.M. (2002). The antiproliferative activity ofresveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alterations of thecell cycle. Biochemical Pharmacology. 64: 1375–1386. doi: 10.1016/S0006-2952(02)01296-0
   PubMed Web of Science ®Google Scholar
• Yang, Z., Xie, Q., Chen, Z., Ni, H., Xia, L., Zhao, Q., Chen, Z., Chen, P. (2019). Resveratrol suppresses the invasion and migration of human gastric cancer cells via inhibition of MALAT1-mediated epithelial-to-mesenchymal transition. Experimental and Therapeutic Medicine. 17: 1569–1578.
   PubMed Web of Science ®Google Scholar
• Fonseca, J., Moradi, F., Maddalena, L.A., Ferreira-Tollstadius, B., Selim, S., Stuart, J.A. (2019). Resveratrol integrates metabolic and growth effects in PC3 prostate cancer cells-involvement of prolyl hydroxylase and hypoxia inducible factor-1. Oncology Letters. 17: 697–705.
   PubMed Web of Science ®Google Scholar
• Storniolo, C.E., Moreno. J.J. (2018). Resveratrol analogs with antioxidant activity inhibit intestinal epithelial cancer Caco-2 cell growth by modulating arachidonic acid cascade. Journal of Agricultural and Food Chemistry. doi: 10.1021/acs.jafc.8b05982.
   Web of Science ®Google Scholar
• Seibel, J., Molzberger, A.F., Hertrampf, T., Laudenbach-Leschowski, U., Diel, P. (2009). Oral treatment with genistein reduces the expression of molecular and biochemical markers of inflammation in a rat model of chronic TNBS-induced colitis. European Journalof Nutrition, 48: 213–220. doi: 10.1007/s00394-009-0004-3
   PubMed Web of Science ®Google Scholar
• Farina, H.G., Pomies, M., Alonso, D.F., Gomez, D.E. (2006). Antitumor and antiangiogenic activity of soy isoflavonegenistein in mouse models of melanoma and breast cancer. Oncology Report. 16: 885–891.
   PubMed Web of Science ®Google Scholar
• Raffoul, J.J., Banerjee, S., Che, M., Knoll, Z.E., Doerge, D.R., Abrams, J., Kucuk, O., Sarkar, F.H., Hillman, G.G. (2007). Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model. International Journal of Cancer. 120: 2491–2498. doi: 10.1002/ijc.22548
   PubMed Web of Science ®Google Scholar
• Sahin, K., Yenice, E., Bilir, B., Orhan, C., Tuzcu, M., Sahin, N., Ozercan, I.H., Kabil, N., Ozpolat, B., Kucuk, O. (2019). Genistein Prevents Development of Spontaneous Ovarian Cancer and inhibits Tumor Growth in Hen Model. Cancer Prevention Research. 0289.
   PubMed Web of Science ®Google Scholar